Back to Trades
Ziegler Christoph Samuel
DirectorCIK 0002123272
Profile
- Filings
- 2
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Ziegler Christoph Samuel, Director, has disclosed $32.7K in transactions — all concentrated in Veraxa Biotech AG - Post de-SPAC (VRXA). Their disclosed trades are heavily weighted toward buying — $32.7K in buys and $0 in sells. The largest single open-market purchase on record is $32.7K in Veraxa Biotech AG - Post de-SPAC. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Oct 21 | VRXA Veraxa Biotech AG - Post de-SPAC | Ziegler Christoph Samuel | Director | Buy | $32.7K |
| Jun 10 | VRXA Veraxa Biotech Holding AG | Ziegler Christoph Samuel | Director | Other | $0 |
2 filings